{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:22:57Z","timestamp":1770448977202,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","sleep-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.sleep.2016.11.025","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T19:00:26Z","timestamp":1485198026000},"page":"171-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Risks associated with use of stimulant medications in patients with obstructive sleep apnea and cardiomyopathy: a case-control study"],"prefix":"10.1016","volume":"32","author":[{"given":"Meghna P.","family":"Mansukhani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhanu Prakash","family":"Kolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.sleep.2016.11.025_bib1","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/kws342","article-title":"Increased prevalence of sleep-disordered breathing in adults","volume":"177","author":"Peppard","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.sleep.2016.11.025_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/sleep\/29.3.375","article-title":"Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders","volume":"29","author":"Kushida","year":"2006","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.sleep.2016.11.025_bib3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.sleep.2016.11.025_bib4","doi-asserted-by":"crossref","first-page":"992","DOI":"10.6061\/clinics\/2013(07)17","article-title":"Lack of reliable clinical predictors to identify obstructive sleep apnea in patients with hypertrophic cardiomyopathy","volume":"68","author":"Nerbass","year":"2013","journal-title":"Clinics"},{"issue":"3","key":"10.1016\/j.sleep.2016.11.025_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/sleep\/29.3.381","article-title":"Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults","volume":"29","author":"Gay","year":"2006","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.sleep.2016.11.025_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/sleep\/29.2.244","article-title":"Oral appliances for snoring and obstructive sleep apnea: a review","volume":"29","author":"Ferguson","year":"2006","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.sleep.2016.11.025_bib7","doi-asserted-by":"crossref","DOI":"10.3310\/hta13040","article-title":"Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis","volume":"13","author":"McDaid","year":"2009","journal-title":"Health Technol Assess"},{"issue":"8","key":"10.1016\/j.sleep.2016.11.025_bib8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/sleep\/29.8.1031","article-title":"Practice parameters for the medical therapy of obstructive sleep apnea","volume":"29","author":"Morgenthaler","year":"2006","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.sleep.2016.11.025_bib9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/sleep\/30.6.711","article-title":"Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning","volume":"30","author":"Weaver","year":"2007","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.sleep.2016.11.025_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/sleep\/34.1.111","article-title":"The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA","volume":"34","author":"Antic","year":"2011","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.sleep.2016.11.025_bib11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5664\/jcsm.26970","article-title":"Evaluation of the safety of modafinil for treatment of excessive sleepiness","volume":"3","author":"Roth","year":"2007","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"12","key":"10.1016\/j.sleep.2016.11.025_bib12","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/sleep\/30.12.1705","article-title":"Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin","volume":"30","author":"Morgenthaler","year":"2007","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.sleep.2016.11.025_bib13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0009-9236(99)70112-8","article-title":"Does short-term treatment with modafinil affect blood pressure in patients with obstructive sleep apnea?","volume":"65","author":"Heitmann","year":"1999","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.sleep.2016.11.025_bib14","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/jcph.77","article-title":"Tako-tsubo cardiomyopathy following modafinil use","volume":"53","author":"Younes","year":"2013","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"21","key":"10.1016\/j.sleep.2016.11.025_bib15","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMcpc079030","article-title":"Case records of the Massachusetts General Hospital. Case 36-2007. A 31-year-old woman with rash, fever, and hypotension","volume":"357","author":"Sabatine","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.sleep.2016.11.025_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2008-2231-20-20","article-title":"Report of methamphetamine use and cardiomyopathy in three patients","volume":"20","author":"Sadeghi","year":"2012","journal-title":"Daru"},{"issue":"45","key":"10.1016\/j.sleep.2016.11.025_bib17","first-page":"2016","article-title":"Life-threatening heart failure caused by ADHD medication. Five case reports described","volume":"109","author":"Wikstrom","year":"2012","journal-title":"Lakartidningen"},{"issue":"6","key":"10.1016\/j.sleep.2016.11.025_bib18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.amjmed.2010.11.031","article-title":"Chemical cardiomyopathies: the negative effects of medications and nonprescribed drugs on the heart","volume":"124","author":"Figueredo","year":"2011","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.sleep.2016.11.025_bib19","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ccd.23036","article-title":"Adderall induced inverted-Takotsubo cardiomyopathy","volume":"78","author":"Alsidawi","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.sleep.2016.11.025_bib20","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1002\/clc.20367","article-title":"A\u00a0comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse","volume":"32","author":"Ito","year":"2009","journal-title":"Clin Cardiol"},{"issue":"2","key":"10.1016\/j.sleep.2016.11.025_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/VHRM.S2410","article-title":"A\u00a0young man with acute dilated cardiomyopathy associated with methylphenidate","volume":"4","author":"Nymark","year":"2008","journal-title":"Vasc Health Risk Manag"},{"issue":"3","key":"10.1016\/j.sleep.2016.11.025_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MJT.0b013e3180ed6291","article-title":"Cardiomyopathy due to ingestion of Adderall","volume":"15","author":"Marks","year":"2008","journal-title":"Am J Ther"},{"issue":"9","key":"10.1016\/j.sleep.2016.11.025_bib23","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.amjcard.2008.06.045","article-title":"Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module)","volume":"102","author":"Diercks","year":"2008","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.sleep.2016.11.025_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.amjmed.2006.01.024","article-title":"The association of methamphetamine use and cardiomyopathy in young patients","volume":"120","author":"Yeo","year":"2007","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.sleep.2016.11.025_bib25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/01.paf.0000188082.68009.10","article-title":"Fatal amphetamine-associated cardiotoxicity and its medicolegal implications","volume":"27","author":"Jacobs","year":"2006","journal-title":"Am J Forensic Med Pathol"},{"issue":"8","key":"10.1016\/j.sleep.2016.11.025_bib26","first-page":"1169","article-title":"Methamphetamine abuse","volume":"76","author":"Winslow","year":"2007","journal-title":"Am Fam Physician"},{"issue":"8","key":"10.1016\/j.sleep.2016.11.025_bib27","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1360-0443.2007.01874.x","article-title":"Methamphetamine and cardiovascular pathology: a review of the evidence","volume":"102","author":"Kaye","year":"2007","journal-title":"Addiction"},{"issue":"1\u20133","key":"10.1016\/j.sleep.2016.11.025_bib28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.forsciint.2011.04.028","article-title":"The unique histology of methamphetamine cardiomyopathy: a case report","volume":"212","author":"Karch","year":"2011","journal-title":"Forensic Sci Int"},{"issue":"9","key":"10.1016\/j.sleep.2016.11.025_bib29","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jama.1991.03460090100040","article-title":"Cardiomyopathy associated with the smoking of crystal methamphetamine","volume":"265","author":"Hong","year":"1991","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.sleep.2016.11.025_bib30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1176\/appi.ajp.2011.11010125","article-title":"Methylphenidate and risk of serious cardiovascular events in adults","volume":"169","author":"Schelleman","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.sleep.2016.11.025_bib31","series-title":"The international classification of sleep disorders: diagnostic and coding manual","year":"2005"},{"issue":"1","key":"10.1016\/j.sleep.2016.11.025_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12012-009-9033-7","article-title":"A\u00a0case of acute cardiomyopathy and pericarditis associated with methylphenidate","volume":"9","author":"Dadfarmay","year":"2009","journal-title":"Cardiovasc Toxicol"},{"issue":"7","key":"10.1016\/j.sleep.2016.11.025_bib33","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3109\/15563650.2013.818684","article-title":"Polymorphisms in CYP2D6 may predict methamphetamine related heart failure","volume":"51","author":"Sutter","year":"2013","journal-title":"Clin Toxicol (Phila)"},{"issue":"12","key":"10.1016\/j.sleep.2016.11.025_bib34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/clc.4960121211","article-title":"Reversible dilated cardiomyopathy induced by methamphetamine","volume":"12","author":"Jacobs","year":"1989","journal-title":"Clin Cardiol"},{"issue":"7","key":"10.1016\/j.sleep.2016.11.025_bib35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1081\/CLT-120026521","article-title":"Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?","volume":"41","author":"Wijetunga","year":"2003","journal-title":"J\u00a0Toxicol Clin Toxicol"},{"issue":"3","key":"10.1016\/j.sleep.2016.11.025_bib36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1258\/rsmmsl.43.3.267","article-title":"Sudden unexpected death of a methamphetamine abuser with cardiopulmonary abnormalities: a case report","volume":"43","author":"Nishida","year":"2003","journal-title":"Med Sci Law"},{"issue":"4","key":"10.1016\/j.sleep.2016.11.025_bib37","first-page":"266","article-title":"Cardiomyopathy characterized by abnormal accumulation of desmin-type intermediate filaments in cardiac muscle fibers. A case report and review of the literature","volume":"39","author":"Tanaka","year":"1989","journal-title":"Acta Pathol Jpn"},{"issue":"3","key":"10.1016\/j.sleep.2016.11.025_bib38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000106681","article-title":"Methamphetamine-associated acute left ventricular dysfunction: a variant of stress-induced cardiomyopathy","volume":"109","author":"Srikanth","year":"2008","journal-title":"Cardiology"},{"issue":"2","key":"10.1016\/j.sleep.2016.11.025_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00000433-199606000-00014","article-title":"Cardiac muscle lesions associated with chronic administration of methamphetamine in rats","volume":"17","author":"He","year":"1996","journal-title":"Am J Forensic Med Pathol"},{"issue":"3","key":"10.1016\/j.sleep.2016.11.025_bib40","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1183\/09031936.00124708","article-title":"Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients","volume":"34","author":"Koutsourelakis","year":"2009","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.sleep.2016.11.025_bib41","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2869.2008.00663.x","article-title":"Determinants of subjective sleepiness in suspected obstructive sleep apnoea","volume":"17","author":"Koutsourelakis","year":"2008","journal-title":"J\u00a0Sleep Res"},{"issue":"6","key":"10.1016\/j.sleep.2016.11.025_bib42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/sleep\/28.6.667","article-title":"Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: a case-control study","volume":"28","author":"Auger","year":"2005","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.sleep.2016.11.025_bib43","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1378\/chest.124.6.2192","article-title":"Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study","volume":"124","author":"Schwartz","year":"2003","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.sleep.2016.11.025_bib44","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1164\/ajrccm.164.9.2103032","article-title":"Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea","volume":"164","author":"Pack","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.sleep.2016.11.025_bib45","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/ajrccm.163.4.2005036","article-title":"Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea\/hypopnea syndrome","volume":"163","author":"Kingshott","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.sleep.2016.11.025_bib46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000196661","article-title":"Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients","volume":"64","author":"Arnulf","year":"1997","journal-title":"Respiration"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945717300242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945717300242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T14:43:38Z","timestamp":1601390618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945717300242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":46,"alternative-id":["S1389945717300242"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2016.11.025","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risks associated with use of stimulant medications in patients with obstructive sleep apnea and cardiomyopathy: a case-control study","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2016.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}